Concepedia

Rahnuma Wahid

RW

13

Publications

856

Citations

12

H-Index

2004

Active since

Affiliations

Program for Appropriate Technology in Health(Current)

Gates Foundation

National Institute for Biological Standards and Control

University of California, San Francisco

Centers for Disease Control and Prevention

Rahnuma Wahid is an author at Program for Appropriate Technology in Health specializing in virology, immunology, and vaccination.

ORCID

Top concepts

Publications per year

2004–2025

13

Publications

13

Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence

Ming Te Yeh, Erika Bujáki, Patrick Dolan et al. · Cell Host & Microbe · 2020 · 215 citations · Full text

, , +16

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

Pierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay et al. · The Lancet · 2019 · 143 citations · Full text

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

David I. Bernstein, Jeffrey T. Guptill, Abdollah Naficy et al. · The Lancet Infectious Diseases · 2019 · 138 citations · Full text

Dendritic Cells and Macrophages Are Productively Infected by Poliovirus

Rahnuma Wahid, Martin J. Cannon, Marie Chow · Journal of Virology · 2004 · 86 citations · Full text

, , +15

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials

Ilse De Coster, Isabel Leroux‐Roels, Ananda S Bandyopadhyay et al. · The Lancet · 2020 · 84 citations · Full text

Rows per page

1–5 of 13